Abstract
Microbes are powerful cell factories for making molecules that are difficult or impossible to produce by other means. Filamentous fungi such as Trichoderma reesei are superior hosts for recombinant protein production, yet secreted proteases often degrade target proteins, reducing yields and limiting process robustness. Preventing proteolysis without relying on expensive commercial inhibitors or compromising strain fitness has been a longstanding challenge in fungal biotechnology, particularly for scaling up production to industrially relevant levels.
This study reports the identification of a native inhibitory protein from T. reesei, TrI9, and shows that directing its secretion into the culture medium markedly reduces extracellular protease activity and enables production of the highly protease-sensitive spider silk–like protein CBM-AQ12-CBM, which could be used in high-performance biomaterials. Computational and in vitro analyses are consistent with TrI9 acting as a multi-target inhibitor of subtilisin-like proteases (SLPs), including SLP2, a protease that cannot be eliminated by gene deletion due to its crucial role in normal growth and development.
This TrI9-based strategy for protease mitigation presents a novel approach for strain improvement, protecting a wide range of protease-labile products beyond silk proteins during large-scale fermentation. Protecting sensitive proteins without added inhibitors offers a cost-effective alternative for scaling up protein production across multiple applications, from protein-based materials manufacturing to pharmaceuticals, as well as enzyme and food applications.
This study reports the identification of a native inhibitory protein from T. reesei, TrI9, and shows that directing its secretion into the culture medium markedly reduces extracellular protease activity and enables production of the highly protease-sensitive spider silk–like protein CBM-AQ12-CBM, which could be used in high-performance biomaterials. Computational and in vitro analyses are consistent with TrI9 acting as a multi-target inhibitor of subtilisin-like proteases (SLPs), including SLP2, a protease that cannot be eliminated by gene deletion due to its crucial role in normal growth and development.
This TrI9-based strategy for protease mitigation presents a novel approach for strain improvement, protecting a wide range of protease-labile products beyond silk proteins during large-scale fermentation. Protecting sensitive proteins without added inhibitors offers a cost-effective alternative for scaling up protein production across multiple applications, from protein-based materials manufacturing to pharmaceuticals, as well as enzyme and food applications.
| Original language | English |
|---|---|
| Article number | 135405 |
| Journal | Bioresource Technology |
| DOIs | |
| Publication status | Accepted/In press - 14 Jul 2026 |
| MoE publication type | A1 Journal article-refereed |
Funding
This project received funding from the Research Council of Finland under grant agreement no 368374, and VTT’s internal funding.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics of 'Protease suppression by native I9 inhibitor improves recombinant protein production in Trichoderma reesei'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver